Limited utility of interatrial block in predicting ischemia on coronary angiography in patients with suboptimal

Vignendra Ariyarajah1, David H Spodick, Jaxon Fernandes

  • 1Preventive Cardiology, Massachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, 150 South Huntington Avenue, Boston, Massachusetts 02130, USA. vignendra@hotmail.com

Insights

Interatrial block (P waves > or = 110 ms) shows limited utility in predicting myocardial ischemia in patients with suboptimal exercise tests. Early P-wave duration changes during exercise may offer better insights for these patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Diagnostic Testing

Background:

  • Interatrial block (P wave duration ≥ 110 ms) is linked to exercise-induced myocardial ischemia.
  • Its role in patients with suboptimal (< 3 min) exercise tolerance tests (ETT) is understudied.

Purpose of the Study:

  • To assess the relationship between resting and exercise-induced P-wave duration changes and coronary artery disease (CAD) in patients with suboptimal ETT.

Main Methods:

  • Prospective study of 51 patients with interatrial block and CAD undergoing coronary angiography after suboptimal ETT.
  • A control group of 64 patients without interatrial block was used for comparison.
  • Obstructive lesions (>70%) on angiography indicated myocardial ischemia.

Main Results:

  • Interatrial block patients had more obstructive coronary lesions, but not statistically significant (p=0.25).
  • A P-wave duration increase > 20 ms during exercise was more frequent in interatrial block patients with positive ETT.
  • New interatrial block development during exercise correlated with significant CAD in patients without baseline interatrial block.

Conclusions:

  • Interatrial block has limited predictive value for myocardial ischemia in suboptimal ETT.
  • Further research on early P-wave duration changes and new interatrial block during exercise could improve ETT interpretation in borderline cases.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...